Quick-Neuron™ Dopaminergic - Human iPSC-derived Neurons Alzheimer's Disease - (M, 71yr, Caucasian, not Latino)
from Alzheimer's Disease patient (M, 71)
As low as ¥366,000.00
Our proprietary transcription factor-based stem cell differentiation method produces neurons without a genetic footprint. Quick-Neuron™ Dopaminergic - Human iPSC-derived Neurons display typical neurite outgrowth and express a variety of neuronal markers, such as TUBB3 (pan-neuronal) and TH (dopaminergic). When thawed and maintained according to the instructions in the user guide, the iPSC-derived neurons are viable long-term and are suitable for a variety of characterization and neurotoxicity assays.
|from Alzheimer's Disease patient (M, 71)
|Component N, Component P, Component D4, Component D5, and Component D6
|iPSCs derived from peripheral blood mononuclear cells (CIRM line CW50147)
|This product is for research use only. It is not approved for use in humans or for therapeutic or diagnostic use.
|Frozen cells should be stored in liquid (vapor phase). The rest of the components should be stored at -20°C.
|Donor Race Ethnicity
|Caucasian, not Latino
|See Resources section for more information.
|Transcription factors delivered by synthetic mRNA
|Dry ice (domestic) or liquid nitrogen (international)
|Donor Age At Sampling